LETTER
4-Bromothiazol-2-yl Magnesium Bromide
133
(8) (a) Dondoni, A.; Fantin, G.; Fogagnolo, M.; Medici, A.;
Pedrini, P. J. Org. Chem. 1988, 53, 1748. (b) Kelly, T. R.;
Jagoe, C. T.; Gu, Z. Tetrahedron Lett. 1991, 32, 4263.
(c) Nickson, T. E. J. Fluorine Chem. 1991, 55, 173.
(d) Nicolaou, K. C.; He, Y.; Roschangar, F.; King, N. P.;
Vourloumis, D.; Li, T. Angew. Chem. Int. Ed. 1998, 37, 84.
(e) Ung, A. T.; Pyne, S. G. Tetrahedron: Asymmetry 1998,
9, 1395.
0.82 (s, 9 H), 2.02 (br s, 2 H), 4.41 (d, 3J = 5.9 Hz, 1 H), 5.04
(d, 3J = 5.9 Hz, 1 H), 7.09 (s, 1 H), 7.19–7.26 (m, 5 H).
13C NMR (90 MHz, CDCl3): d = –5.3, –4.8, 18.0, 25.7, 60.6,
78.2, 117.0, 124.3, 127.0, 128.0, 128.1, 140.1, 173.9. Anal.
Calcd for C17H25BrN2OSSi (413.45): C, 49.39; H, 6.09; N,
6.78. Found: C, 49.45; H, 6.11; N, 6.71. The erythro-
diastereoisomer (0.47g, 1.13 mmol, 11%) was obtained as a
yellow liquid.
(9) Abarbri, A.; Thibonnet, J.; Berillon, L.; Dehmell, F.;
Rottländer, M.; Knochel, P. J. Org. Chem. 2000, 65, 4618.
(10) Selva, E.; Ferrari, P.; Kurz, M.; Tavecchia, P.; Colombo, L.;
Stelle, S.; Restelli, E.; Goldstein, B. P.; Ripamonti, F.;
Denaro, M. J. Antibiot. 1995, 48, 1039.
(11) (a) Okumura, K.; Saito, H.; Shin, C.; Umemura, K.;
Yoshimura, J. Bull. Chem. Soc. Jpn. 1998, 71, 1863.
(b) Okumura, K.; Suzuki, T.; Shin, C. Heterocycles 2000,
53, 765.
(15) The relative configuration was proven by converting the
aminoalcohol 4 and its erythro-diastereoisomer into the
corresponding cyclic N-Boc protected N,O-acetals which
were studied independently by 1H NMR spectroscopy. In
addition, a known acetal11 was prepared by carboxylation of
product 5 at carbon atom C-4 (t-BuLi, CO2 in Et2O),
transformation into the corresponding ester (EtI in DMF),
TBS-deprotection (TBAF in THF) and acetal formation
(2,2-dimethoxypropane, TsOH in CH2Cl2). The
(12) Brussee, J.; Loos, W. T.; Kruse, C. G.; van der Gen, A.
Tetrahedron 1990, 46, 979.
(13) Brussee, J.; Dofferhoff, F.; Kruse, C. G.; van der G en, A.
Tetrahedron 1990, 46, 1653.
enantiomeric excess (95% ee) was determined by HPLC
analysis of the N-Boc protected product 5 (column:
Machery-Nagel, Nucleodex b-OH, 200 × 4.00 mm; eluent:
H2O/MeCN 20:80→0:100 over 30 min; flow rate: 1.0 mL/
min).
(14) Procedure for the Conversion 1→4: At 0 °C, 6.60 mL
(12.0 mmol) of a 1.80 M i-PrMgBr solution in Et2O was
added dropwise to a solution of 2.92 g (12.0 mmol) 2,4-
dibromothiazole in 30 mL of THF and the solution was
stirred for 15 min at 0 °C. Neat TBS-protected mandelo-
nitrile12 (2.47 g, 10.0 mmol) was added dropwise. The
mixture was stirred for 30 min at 0 °C and for another 30 min
at r.t. After adding 10 mL of EtOH the reaction mixture was
cooled to –78 °C and NaBH4 (0.76 g, 20.0 mmol) was added
carefully in small portions. The mixture was stirred for 2 h at
–78 °C and – after removing the cooling bath – over night at
r.t. The reaction mixture was quenched with 25 mL of sat. aq
NH4Cl solution and diluted with 200 mL Et2O. The organic
layer was washed with 200 mL H2O and 100 mL brine and
it was subsequently dried over Na2SO4. GC analysis
indicated a facial diastereoselectivity of 79:21. After
filtration the solvent was removed and the residue was
purified by flash chromatography (pentane/Et2O:
75:25→50:50). Compound 4 (2.55 g, 6.18 mmol, 62%) was
obtained as a yellow liquid. [a]D20 –47.9 (c 1.5, CHCl3). 1H
NMR (360 MHz, CDCl3): d = –0.21 (s, 3 H), –0.06 (s, 3 H),
(16) Sone, H.; Kondo, T.; Kiryu, M.; Ishiwata, H.; Ojika, M.;
Yamada, K. J. Org. Chem. 1995, 60, 4774.
(17) Corey, E. J.; Shibata, S.; Bakshi, R. K. J. Org. Chem. 1988,
53, 2861.
(18) Analytical data of compound 8: [a]D20 +27.5 (c 0.80,
CHCl3). 1H NMR (360 MHz, CDCl3): d = 0.92 (d, 3J = 6.8
Hz, 3 H), 1.02 (d, 3J = 6.8 Hz, 3 H), 2.14–2.30 (m, 1 H), 2.60
(br s, 1 H), 4.80 (d, 3J = 4.8 Hz, 1 H), 7.19 (s, 1 H). 13C NMR
(90 MHz, CDCl3): d = 16.2, 18.8, 34.9, 76.4, 116.7, 124.3,
175.6. Anal. Calcd for C7H10BrNOS (236.13): C, 35.61; H,
4.27; N, 5.93. Found: C, 35.81; H, 4.38; N, 5.87.
(19) Analytical data of compound 11: [a]D20 +26.9 (c 1.15,
CHCl3). 1H NMR (360 MHz, CDCl3): d = 0.93 (d, 3J = 6.6
Hz, 3 H), 1.03 (d, 3J = 7.0 Hz, 3 H), 2.08 (br s, 1 H), 2.20–
2.35 (m, 1 H), 3.94 (s, 3 H), 4.82 (d, 3J = 4.8 Hz, 1 H), 8.16
(s, 1 H). 13C NMR (90 MHz, CDCl3): d = 16.2, 18.9, 35.0,
52.4, 76.7, 127.6, 146.4, 161.9, 175.7. Anal. Calcd for
C9H13NO3S (215.27): C, 50.21; H, 6.09; N, 6.51. Found: C,
49.91; H, 6.20; N, 6.29.
Synlett 2004, No. 1, 131–133 © Thieme Stuttgart · New York